Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kennelly

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Advances in Therapy|December 18, 2021
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWURJeffrey Frankel, David Staskin, Susann Varano, et al.
Journal of Clinical Medicine|December 11, 2025
Characterizing Urine and Sediment in Individuals with Lower Urinary Tract Dysfunction Utilizing Intermittent CathetersPer Bagi, Christina Kruuse, Christian Forman, et al.
European Urology|April 11, 2022
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)Michael Kennelly, Francisco Cruz, Sender Herschorn, et al.
Neurourology and Urodynamics|November 2, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)Pierre Denys, Juan Carlos Castaño Botero, Ricardo Luis Vita Nunes, et al.
Open Forum Infectious Diseases|February 23, 2026
Prevention Strategies for All Hospital-Onset Urinary Tract Infections: Best Practice Consensus RecommendationsEdward J Septimus, Lily A Arya, Rebecca Crapanzano-Sigafoos, et al.
Neurourology and Urodynamics|April 28, 2020
One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinenceKevin Benson, Rebecca McCrery, Chris Taylor, et al.
Neurourology and Urodynamics|January 28, 2021
Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation systemAndrea Pezzella, Rebecca McCrery, Felicia Lane, et al.
The Journal of Urology|July 27, 2019
Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM StudyRebecca McCrery, Felicia Lane, Kevin Benson, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Advances in Therapy|December 18, 2021
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWURJeffrey Frankel, David Staskin, Susann Varano, et al.
Journal of Clinical Medicine|December 11, 2025
Characterizing Urine and Sediment in Individuals with Lower Urinary Tract Dysfunction Utilizing Intermittent CathetersPer Bagi, Christina Kruuse, Christian Forman, et al.
European Urology|April 11, 2022
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)Michael Kennelly, Francisco Cruz, Sender Herschorn, et al.
Neurourology and Urodynamics|November 2, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)Pierre Denys, Juan Carlos Castaño Botero, Ricardo Luis Vita Nunes, et al.
Open Forum Infectious Diseases|February 23, 2026
Prevention Strategies for All Hospital-Onset Urinary Tract Infections: Best Practice Consensus RecommendationsEdward J Septimus, Lily A Arya, Rebecca Crapanzano-Sigafoos, et al.
Neurourology and Urodynamics|April 28, 2020
One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinenceKevin Benson, Rebecca McCrery, Chris Taylor, et al.
Neurourology and Urodynamics|January 28, 2021
Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation systemAndrea Pezzella, Rebecca McCrery, Felicia Lane, et al.
The Journal of Urology|July 27, 2019
Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM StudyRebecca McCrery, Felicia Lane, Kevin Benson, et al.
Pageof 4